Proteomics in cancer cell research: an analysis of therapy resistance

被引:15
作者
Lage, H [1 ]
机构
[1] Humboldt Univ, Inst Pathol, Charite, D-10117 Berlin, Germany
关键词
2D-PAGE; cancer; drug resistance; thermoresistanee;
D O I
10.1016/j.prp.2004.02.003
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Proteomics, the global analysis of expressed cellular proteins, provides powerful tools for the detailed comparison of proteins from normal and neoplastic tissue. In particular, cancer cell culture models are suited for applying proteomics techniques, such as two-dimensional polyacrylamide get electrophoresis (2D-PAGE) and mass spectrometry, to identify specific protein expression profiles and/or proteins that may be associated with a defined phenotype of the cancer cells. As an instance of such an application of proteomics techniques, the detailed proteome analyses of different drug-resistant and thermoresistant cancer cell lines will be discussed. Finally, the potential roles of newly identified factors in a distinct biological mechanism have to be proven by functional studies. This experimental validation strategy will be discussed for two different factors identified by 2D-PAGE analyses of drug-resistant carcinoma cell lines, the "transporter associated with antigen presentation 1" (TAP 1) and 14-3-3sigma. (C) 2004 Elsevier GmbH. All rights reserved.
引用
收藏
页码:105 / 117
页数:13
相关论文
共 103 条
  • [1] Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer
    Adam, PJ
    Boyd, R
    Tyson, KL
    Fletcher, GC
    Stamps, A
    Hudson, L
    Poyser, HR
    Redpath, N
    Griffiths, M
    Steers, G
    Harris, AL
    Patel, S
    Berry, J
    Loader, JA
    Townsend, RR
    Daviet, L
    Legrain, P
    Parekh, R
    Terrett, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) : 6482 - 6489
  • [2] Growth signaling in breast cancer cells: outcomes and promises of proteomics
    Adriaenssens, E
    Lemoine, J
    El Yazidi-Belkoura, I
    Hondermarck, H
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) : 797 - 803
  • [3] P-glycoprotein: from genomics to mechanism
    Ambudkar, SV
    Kimchi-Sarfaty, C
    Sauna, ZE
    Gottesman, MM
    [J]. ONCOGENE, 2003, 22 (47) : 7468 - 7485
  • [4] A comparison of selected mRNA and protein abundances in human liver
    Anderson, L
    Seilhamer, J
    [J]. ELECTROPHORESIS, 1997, 18 (3-4) : 533 - 537
  • [5] Proteomics: new perspectives, new biomedical opportunities
    Banks, RE
    Dunn, MJ
    Hochstrasser, DF
    Sanchez, JC
    Blackstock, W
    Pappin, DJ
    Selby, PJ
    [J]. LANCET, 2000, 356 (9243) : 1749 - 1756
  • [6] Automated subcellular localization and quantification of protein expression in tissue microarrays
    Camp, RL
    Chung, GG
    Rimm, DL
    [J]. NATURE MEDICINE, 2002, 8 (11) : 1323 - 1327
  • [7] 14-3-3σ is required to prevent mitotic catastrophe after DNA damage
    Chan, TA
    Hermeking, H
    Lengauer, C
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE, 1999, 401 (6753) : 616 - 620
  • [8] Proteomics reveals protein profile changes in doxorubicin - treated MCF-7 human breast cancer cells
    Chen, ST
    Pan, LT
    Tsai, YC
    Huang, CM
    [J]. CANCER LETTERS, 2002, 181 (01) : 95 - 107
  • [9] DIETEL M, 1990, CANCER RES, V50, P6100
  • [10] Phage display of proteins
    Dunn, IS
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1996, 7 (05) : 547 - 553